MetLife stock: Mizuho lifts price target to 117 dollars
Published on 11/21/2026 at 11:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view supports MetLife
- Mizuho retained its Outperform rating after updating its life-insurance models.
- The analyst action followed MetLife's third-quarter performance and a disability expert call.
- The insurer's capital allocation and business momentum remain central topics for investors.
Mizuho raised its price target for MetLife on Thursday, November 12, while keeping its Outperform rating, according to TradingView. The move followed an update to Mizuho's life-insurance models after MetLife's third-quarter results and a disability expert call.
Updated view on insurance earnings
The analyst maintained the positive rating as the insurer's operating momentum remained in focus. MetLife's third-quarter performance had drawn attention to broad-based business activity, while the revised model supported a higher target.
For investors, the action adds an external assessment to the company's growth and capital-allocation discussion. The rating was unchanged, so the main development was the higher valuation target rather than a shift in Mizuho's stance.
Lang & Schwarz quote on Saturday
MetLife stock traded at 87.57 euros on Lang & Schwarz at 11:08 CET on Saturday, November 21, 2026.
MetLife Inc. stock facts
- Company: MetLife Inc.
- ISIN: US59156R1086
- Quote: 87.57 euros on Lang & Schwarz at 11:08 CET on November 21, 2026
Broader market direction remains relevant for financial stocks. See Current market reports for the latest market context.
More company coverage is available in More news and analyses on MetLife stock.
